Dynamic Susceptibility Contrast Perfusion MR Imaging of Multiple Sclerosis Lesions: Characterizing Hemodynamic Impairment and Inflammatory Activity

References

1. ↵
   Putnam TJ. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med 1933;209:786–790

   CrossRefWeb of Science
2. ↵
   Dawson JW. The histology of disseminated sclerosis: transactions of the Royal Society of Edinburgh.1916;50:517–740
3. ↵
   Tanaka R, Iwasaki Y, Koprowiski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 1975;81:467–478

   PubMedWeb of Science
4. ↵
   Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707–717

   CrossRefPubMedWeb of Science
5. Lassmann H, Reindl M, Rauschka H, et al. A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions. Brain 2003;126(Pt 6):1347–1357
6. ↵
   Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003;206:187–191

   CrossRefPubMedWeb of Science
7. ↵
   Putnam TJ. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Neuropsychol 1935;32:1298–1321
8. ↵
   Wakefield AJ, More LJ, Difford J, McLaughlin JE. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994;47:129–133

   Abstract/FREE Full Text
9. ↵
   Haselhorst R, Kappos L, Bilecen D, et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J Magn Reson Imaging 2000;11:495–505

   CrossRefPubMedWeb of Science
10. ↵
    Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004;127(Pt 1):111–119
11. ↵
    Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–641

    PubMedWeb of Science
12. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–725

    CrossRefPubMedWeb of Science
13. ↵
    Wirestam R, Andersson L, Ostergaard L, et al. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med 2000;43:691–700

    CrossRefPubMedWeb of Science
14. ↵
    Ostergaard L, Hochberg FH, Rabinov JD, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300–305

    PubMedWeb of Science
15. ↵
    Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;174:1147–1157

    PubMed
16. Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003;227:593–600

    PubMedWeb of Science
17. ↵
    Law M, Saindane AM, Ge Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in the normal-appearing white matter. Radiology 2004;231:645–652

    CrossRefPubMedWeb of Science
18. ↵
    Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–721

    PubMedWeb of Science
19. Calamante F, Lythgoe MF, Pell GS, et al. Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5 T. Magn Reson Med 1999;41:479–485

    CrossRefPubMedWeb of Science
20. ↵
    Chang L, Ernst T, Leonido-Yee M, Speck O. Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 2000;54:389–396

    Abstract/FREE Full Text
21. ↵
    Aronen HJ, Perkio J, Karonen JO, et al. Perfusion-weighted MRI in human acute ischemic stroke: a comparison with the progression of the infarct on diffusion-weighted images. Acad Radiol 2002;9 (suppl 1):S160–S164
22. Derdeyn CP, Powers WJ, Grubb RL Jr. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 1998;19:1463–1469

    Abstract
23. ↵
    Aksoy FG, Lev MH. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. Semin Ultrasound CT MR 2000;21:462–477

    CrossRefPubMedWeb of Science
24. ↵
    Adams CW, Poston RN, Buk SJ. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci 1989;92:291–306

    CrossRefPubMedWeb of Science
25. ↵
    Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis: its significance for the pathogenesis of multiple sclerosis. Brain 1987;110(Pt 2):405–414
26. ↵
    Semenza GL. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 2000;106:809–812

    CrossRefPubMedWeb of Science
27. ↵
    Zamvil SS, Steinman L. Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of multiple sclerosis. Neurology 2002;59:970–971

    FREE Full Text
28. ↵
    Giubilei F, Antonini G, Di Legge S, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 2002;106:109–112

    CrossRefPubMedWeb of Science
29. ↵
    Sims DE. Recent advances in pericyte biology: implications for health and disease. Can J Cardiol 1991;7:431–443

    PubMedWeb of Science
30. ↵
    Chakravarthy U, Stitt AW, McNally J, Bailie JR, Hoey EM, Duprex P. Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes. Curr Eye Res 1995;14:285–294

    PubMedWeb of Science
31. Hirschi KK, D’Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996;32:687–698

    CrossRefPubMedWeb of Science
32. ↵
    Seilhean D, Kobayashi K, He Y, et al. Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol (Berl) 1997;93:508–517

    CrossRefPubMed
33. ↵
    Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29

    CrossRefPubMedWeb of Science
34. ↵
    Latchaw RE. The roles of diffusion and perfusion MR imaging in acute stroke management. AJNR Am J Neuroradiol 1999;20:957–959

    FREE Full Text
35. ↵
    Guo AC, Jewells VL, Provenzale JM. Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. AJNR Am J Neuroradiol 2001;22:1893–1900

    Abstract/FREE Full Text
36. ↵
    Guseo A, Jellinger K. The significance of perivascular infiltrations in multiple sclerosis. J Neurol 1975;211:51–60

    CrossRefPubMedWeb of Science
37. ↵
    Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions: a study of 113 cases. Brain 1999;122(Pt 12):2279–2295
38. ↵
    Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304–311

    Abstract/FREE Full Text
39. ↵
    Adams CW, Abdulla YH, Torres EM, Poston RN. Periventricular lesions in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neuropathol Appl Neurobiol 1987;13:141–152

    CrossRefPubMed
40. ↵
    Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039–1042

    Abstract/FREE Full Text